• LAST PRICE
    6.1200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 6.1200
  • Day Range
    ---
  • 52 Week Range
    Low 3.3600
    High 11.5600
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 6.11
TimeVolumeMXCT
09:32 ET68656.18
09:35 ET16006.0412
09:42 ET3006.16
09:48 ET1006.16
09:53 ET4006.195
09:55 ET6006.17
10:00 ET2016.1
10:02 ET2006.09
10:04 ET2006.075
10:13 ET2006.1
10:24 ET2006.14
10:29 ET1006.125
10:38 ET4006.165
10:49 ET1006.195
10:56 ET7086.19
10:58 ET2006.2
11:00 ET3546.19
11:02 ET2006.2
11:09 ET1506.23
11:14 ET1006.22
11:16 ET13006.19
11:20 ET8006.182
11:23 ET1006.21
11:25 ET3006.21
11:27 ET2006.195
11:30 ET7006.175
11:32 ET1006.17
11:34 ET1006.18
11:38 ET4946.19
11:39 ET2006.18
11:41 ET10006.14
11:52 ET11006.14
11:56 ET1006.135
11:57 ET2396.12
12:08 ET1046.11
12:15 ET3356.11
12:24 ET1006.11
12:28 ET5536.12
12:30 ET3006.13
12:32 ET1006.12
12:33 ET2006.11
12:35 ET7806.09
12:37 ET3006.085
12:50 ET1006.1
12:53 ET1006.08
12:55 ET4296.1
12:57 ET12106.12
01:00 ET165376.12
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMXCT
MaxCyte Inc
624.5M
-25.7x
---
United StatesBNGO
Bionano Genomics Inc
659.2M
-5.4x
---
United StatesBFLY
Butterfly Network Inc
611.7M
-4.0x
---
United StatesNUTX
Nutex Health Inc
786.2M
-1.6x
---
United StatesNNOX
Nano-X Imaging Ltd
559.3M
-6.7x
---
United StatesAKYA
Akoya Biosciences Inc
487.4M
-7.0x
---
As of 2022-11-28

Company Information

MaxCyte, Inc. is a commercial cell engineering company. The Company is focused on providing enabling platform technologies to advance cell-based research and development, as well as next-generation cell therapeutic discovery, development and commercialization. The Company has developed and commercialized its Flow Electroporation platform, which facilitates complex engineering of a variety of cells. Its ExPERT platform is based on its Flow Electroporation technology, which has been designed to address the cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. Its ExPERT platform consists of three instruments, which are known as the ATx, STx and GTx. The Company has also developed CARMA, a therapeutic platform based on transfecting mRNA into unstimulated cells for the development of immune cell therapies.

Contact Information

Headquarters
22 FIRSTFIELD ROAD, SUITE 250GAITHERSBURG, MD, United States 20878
Phone
301-517-5556
Fax
301-944-1703

Executives

Non-Executive Independent Chairman of the Board
Richard Douglas
President, Chief Executive Officer, Director
Douglas Doerfler
Interim Chief Financial Officer
Ronald Holtz
Executive Vice President, General Counsel, Corporate Secretary
Maher Masoud
Executive Vice President, Global Sales and Marketing
Thomas Ross

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$624.5M
Revenue (TTM)
$42.0M
Shares Outstanding
102.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.24
Book Value
$2.60
P/E Ratio
-25.7x
Price/Sales (TTM)
14.9
Price/Cash Flow (TTM)
---
Operating Margin
-60.88%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.